| Catalog Number |
74022123 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Pain (1994); Deformity/ Disfigurement (2360); Insufficient Information (4580)
|
| Date of Event |
01/01/2016
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Internal complaint reference: (b)(4).This complaint was opened by smith+nephew to document a patient complication reported that includes reference to the use of a smith+nephew product without evidence about a specific product problem.The reported complication relates to known inherent procedural risks that are appropriately documented in our risk files.Smith+nephew will continue to monitor trends in accordance with our post-market surveillance process and take necessary action as required if anticipated severity and/or occurrence rates are exceeded.Smith+nephew has no reason to suspect that the product failed to meet any specifications at the time of manufacture.Based on our review of all currently available information, we are unable to confirm a relationship between the reported event and the device or identify a definitive root cause.However, as the use of our product cannot be excluded as a potential cause or contributory factor to the reported issue, we are submitting this report in accordance with applicable regulations.If additional investigative findings or information becomes available that alter the conclusions of this report, a follow-up report will be submitted as required.
|
| |
|
Event or Problem Description
|
|
It was reported that after a tka that took place on (b)(6) 2015, a revision surgery took place on (b)(6) 2022 due to an unknown reason.In this surgery, a jrny ii bcs femoral oxin lt sz 3, a jrny ii bcs xlpe art isrt sz 3-4 lt 9mm and a journey tibia base np lt sz 4 were explanted.No further details at this time.
|
| |
|
Event or Problem Description
|
|
It was reported that after a tka that took place on (b)(6) 2015, the patient started experiencing patellofemoral pain and maltracking of the patella on (b)(6) 2016.This adverse event was address by a revision surgery on (b)(6) 2021.In this surgery, a jrny ii bcs femoral oxin lt sz 3, a jrny ii bcs xlpe art isrt sz 3-4 lt 9mm and a journey tibia base np lt sz 4 were explantd.No further details at this time.
|
| |
|
Additional Manufacturer Narrative
|
|
Internal complaint reference: (b)(4).New information was provided regarding the reason of the revision surgery, and the revision date was corrected.Sections b5, d6b and h6 were updated.
|
| |
|
Search Alerts/Recalls
|